ViewRay, Inc. designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company's software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered. MRIdian delivers radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian provides real-time imaging that defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment. MRIdian allows physicians to record the level of radiation exposure that the tumor has received and adapt the prescription between fractions as needed.

2.8 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

Viewray has received 55.51% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Viewray and other stocks. Vote “Outperform” if you believe VRAY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VRAY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Do Wall Street analysts recommend investors buy shares of Viewray?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viewray in the last year. There are currently 1 sell rating, 3 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Viewray.

When is Viewray's next earnings date?

How were Viewray's earnings last quarter?

Viewray Inc (NASDAQ:VRAY) issued its quarterly earnings data on Thursday, April, 30th. The company reported ($0.19) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.19). The firm earned $14.25 million during the quarter, compared to the consensus estimate of $12.47 million. Viewray had a negative return on equity of 71.37% and a negative net margin of 139.91%. View Viewray's earnings history.

What guidance has Viewray issued on next quarter's earnings?

Viewray updated its FY 2020
After-Hours earnings guidance on Thursday, March, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $58-95 million, compared to the consensus revenue estimate of $110.15 million.

What price target have analysts set for VRAY?

10 analysts have issued 1-year price targets for Viewray's stock. Their forecasts range from $2.00 to $8.00. On average, they expect Viewray's share price to reach $5.17 in the next year. This suggests a possible upside of 117.1% from the stock's current price. View analysts' price targets for Viewray.

Has Viewray been receiving favorable news coverage?

News coverage about VRAY stock has trended extremely negative this week, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Viewray earned a daily sentiment score of -5.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future. View the latest news aboutViewray.

When did Viewray IPO?

(VRAY) raised $52 million in an initial public offering (IPO) on the week of April 6th 2015. The company issued 4,000,000 shares at $12.00-$14.00 per share. Cowen and Company and Stifel served as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

Which major investors are buying Viewray stock?

VRAY stock was bought by a variety of institutional investors in the last quarter, including Hudson Executive Capital LP, BlackRock Inc., Needham Investment Management LLC, Silvercrest Asset Management Group LLC, State Street Corp, Geode Capital Management LLC, UBS Group AG, and Nuveen Asset Management LLC. Company insiders that have bought Viewray stock in the last two years include International Ltd Fosun, Scott William Drake, and Shahriar Matin. View insider buying and selling activity for Viewray.

How do I buy shares of Viewray?

Shares of VRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Viewray's stock price today?

One share of VRAY stock can currently be purchased for approximately $2.38.

How big of a company is Viewray?

Viewray has a market capitalization of $350.81 million and generates $87.78 million in revenue each year. The company earns $-120,200,000.00 in net income (profit) each year or ($1.18) on an earnings per share basis.